SEC Form 4 · accession 0001127602-18-010078
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory F Covino
Officer — VP, Chief Accounting Officer
Period of report
Mar 1, 2018
Accepted (ET)
Mar 5, 2018 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | $0.00 | Mar 1, 2018 | A | 531 | A | — | Mar 1, 2021 | Common Stock | 531 | 531 | D |
Explanation of responses
- F1The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 03/01/2018.